Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) shares saw an uptick in trading volume on Tuesday . 13,179 shares were traded during mid-day trading, an increase of 303% from the previous session’s volume of 3,268 shares.The stock last traded at $9.3010 and had previously closed at $9.2364.
Bavarian Nordic Price Performance
The stock has a 50 day simple moving average of $9.65 and a two-hundred day simple moving average of $9.89. The company has a market cap of $2.21 billion, a price-to-earnings ratio of 12.24 and a beta of 1.19.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last issued its earnings results on Wednesday, May 13th. The company reported $0.01 earnings per share (EPS) for the quarter. Bavarian Nordic had a return on equity of 9.32% and a net margin of 19.74%.The business had revenue of $165.70 million during the quarter.
About Bavarian Nordic
Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.
The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.
Read More
- Five stocks we like better than Bavarian Nordic
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
- These 3 Dividend Stocks Could Boost Your Income This July
- Rocket Lab Defies Gravity With $8B Buyout
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
